Barcelona, Spain

Gendiag.exe, S.l.

Calculating rank
USPTO Granted Patents = 4



Forward Citations = 2

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Eduardo Salas (3 out of 3 patents)

silverMedal José Manuel Soria (3 out of 3 patents)

bronzeMedal Miroslava Ogorelkova (3 out of 3 patents)

4.  Roberto Elosua Llanos (3 out of 5 patents)

5.  Joan Vila (3 out of 3 patents)

6.  Sergio Castillo Fernandez (2 out of 4 patents)

7.  Sergio Castillo (2 out of 2 patents)

8.  Roberto Elosua (1 out of 1 patent)

9.  Eduardo Salas Pérez-Rasilla (1 out of 1 patent)

10.  Jaume Marrugat De La Iglesia (1 out of 3 patents)

11.  Joan Salgado Gómez (1 out of 2 patents)

12.  Jose Maria Ordovás Munoz (1 out of 1 patent)

13.  Eduardo Salas Perez-Rasilla (5 patents)

14.  José Maria Ordovás Munoz (1 patent)

15.  Sara Pich (0 patent)


4 patents:

Company Overview
Gendiag.exe, S.l. is a leading biotechnology company specializing in the development of innovative diagnostic solutions. With a strong focus on research and development, we strive to provide accurate and reliable testing services for various genetic and infectious diseases. Our state-of-the-art technology and highly skilled team ensure high-quality results and timely delivery to meet the needs of our clients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#134 in Barcelona

#516 in Spain

Barcelona, ES
Barcelona, Spain
Forward Citations = 2

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gendiag.exe, S.l.. Retrieved from https://idiyas.com/company/gendiag-exe-s-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…